Coeliac disease in the older patient

Reviews in Clinical Gerontology

Volumn 16, Issue 4, 2006, Pages 291-300

  Quinn, C J ^a   Cotter, P E ^a   Stevens, F M ^a   O'Keeffe, S T ^a,b  

^a UNIVERSITY HOSPITAL GALWAY   (Ireland)

^b Merlin Park University Hospital   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CORTICOSTEROID; GLUTEN; HLA DQ2 ANTIGEN; PROTEINASE; ZINC;

ATAXIA; AUTOIMMUNITY; BILIARY TRACT DISEASE; BLOOD ANALYSIS; BONE DENSITOMETRY; CELIAC DISEASE; DERMATITIS HERPETIFORMIS; DIAGNOSTIC PROCEDURE; DIET SUPPLEMENTATION; ENVIRONMENTAL FACTOR; EPILEPSY; GASTROINTESTINAL BIOPSY; GASTROINTESTINAL SYMPTOM; GLUTEN FREE DIET; HEREDITY; HISTOPATHOLOGY; HUMAN; INTESTINE BIOPSY; LIVER DISEASE; MALIGNANT TRANSFORMATION; MASS SCREENING; NEUROLOGIC DISEASE; PATHOGENESIS; PERIPHERAL NEUROPATHY; REVIEW; SENESCENCE; SERODIAGNOSIS; SEROLOGY; ULCERATIVE COLITIS;

EID: 35648938072     PISSN: 09592598     EISSN: 14699036     Source Type: Journal    
DOI: 10.1017/S0959259807002250     Document Type: Review

References (109)

1. Paulley JW, Fairweather FA, Leemin A. Postgastrectomy steatorrhoea and patchy jejunal atrophy. Lancet 1957; 1: 406-07.
2. Gregory C, Ashworth M, Eade OE, Holdstock G, Smith CL, Wright R. Delay in diagnosis of adult coeliac disease. Digestion 1983; 28: 201-04.
3. Croese J, Harris O, Bain B. Coeliac disease: haematological features, and delay in diagnosis. Med J Aust 1979; 2: 335-38.
4. Shanahn F, Weinstein WM. Extending the scope in celiac disease. N Eng J Med 1988; 319: 282-83.
5. Hankey GI, Holmes GKT. Coeliac disease in the elderly. Gut 1994; 35: 65-67.
6. Marsh MN. Gluten, major histocompatibility complex and the small intestine. A molecular and immunobiologic approach to the spectrum of gluten sensitivity (coeliac sprue). Gastroenterology 1992; 102: 330-54.
7. Catassi C, Ratsch IM, Fabiani E et al. Coeliac disease in the year 2000: exploring the iceberg. Lancet 1994; 343: 200-03.
8. Maki M, Collin P. Coeliac disease. Lancet 1997; 349: 1755-59.
9. Corazza GR, Di Sario A, Cecchetti L et al. Influence of pattern of clinical presentation and of gluten-free diet on bone mass and metabolism in adult celiac disease. Bone 1996; 18: 525-30.
10. Walker-Smith JA, Guandalini S, Schmitz J, Shmerling DH, Visakorpi JK. Revised criteria for diagnosis of celiac disease. Report of Working Group of European Society of Paediatric Gastroenterology and Nutrition. Arch Dis Child 1990; 65: 909-11.
11. Meeuwisse GW. Round-table discussion. Diagnostic criteria in celiac disease. Acta Paediatr Scand 1970; 59: 461-63.
12. British Society of Gastoenterology. Guidelines for the management of patients with coeliac disease (April 2002). www.bsg.org.uk/clinical_prac/ guidelines/coeliac.htm
13. Logan RFA. The epidemiology of celiac disease. In: Marsh MN ed. Coeliac disease. Oxford: Blackwell, 1992: 192-214.
14. Stevens FM, Egan-Mitchell B, McCarthy CF, McNicholl B. Factors in the epidemiology of celiac disease in the West of Ireland. In: McConnell RB ed. The genetics of celiac disease. Liverpool: MTP Press, 1979: 7-14.
15. Hellart C, Gotthard R, Jansson G, Norrby K, Walan A. Similar prevalence of celiac disease in children and middle-aged adults in a district of Sweden. Gut 1983; 24: 389-91.
16. Logan RFA, Rifkind EA, Busattil A, Gilmour HM, Fergusan A. Prevalence and incidence of celiac disease in Edinburgh and the Lothian region of Scotland. Gastroenterology 1986; 90: 334-42.
17. Duggan JM. Recent developments in our understanding of coeliac disease. Med J Aust 1997; 166: 312-15.
18. Talley NJ, Valdouvinos M, Petterson TM et al. Epidemiology of celiac sprue: a community-based study. Am J Gastroenterol. 1994; 89: 843-46.
19. Fasano A, Berti I, Geraduzzi T et al. Prevalence of celiac disease in at-risk and not-at-risk groups in the United States; a large multicenter study. Arch Intern Med 2003; 163: 286-92.
20. Bingley PJ, Williams AJ, Narcross AJ et al. Undiagnosed celiac disease at age seven: population-based prospective birth cohort study. BMJ 2004; 328: 322-23.
21. Maki M, Mustalahti K, Kokkonen J et al. Prevalence of celiac disease among children in Finland. N Eng J Med 2003; 348: 2517-24.
22. West J, Logan RF, Hill PG et al. Seroprevalence, correlates, and characteristics of untreated coeliac disease in England. Gut 2003; 52: 960-65.
23. Not T, Horvat K, Hill ID et al. Endomysium antibodies in blood donors predicts high prevalence of celiac disease in the USA. Gastroenterol 1996; 110: A351.
24. Jansen TL, Mulder CJ, Karssen PHZ, Wagenaar CG. Epidemiological survey of the Dutch Celiac disease society: update 1992. Eur J Gastroenterol Hepatol 1993; 5: 73-78.
25. Loft DE. The epidemiology and diagnosis of coeliac disease. Eur J Gastroenterol Hepatol 1993; 5: 69-72.
26. Ferguson et al. Intraepithelial lymphocyte counts in small-intestinal biopsies from children with diarrhoea. Acta Paed Scand. 1976; 65: 541-46.
27. Dietrich W et al. Identification of tissue transglutaminase as autoantigen of celiac disease. Nature Med 1997; 3: 797-801.
28. Sollid LM. Celiac disease: dissecting a complex inflammatory disorder. Nature Rev Immunol 2002; 2: 647-55.
29. Jabri B, Sollid LM. Mechanisms of disease: Immunopathogenesis of celiac disease. Nat Clin Gastroenterol Hepatol 2006; 9: 516-25.
30. Sollid LM, Lie BA. Celiac disease genetics: current concepts and practical applications. Clin Gastroenterol Hepatol 2005; 3: 843-51.
31. Sollid LM, Thorsby E. HLA susceptibility genes in celiac disease: genetic mapping and role in pathogenesis. Gastroenterology 1993; 105: 910-22.
32. Bevan S, Popat S, Braeggar CP et al. Contribution of the MHC region to the familial risk of celiac disease. J Med Gent 1999; 36: 687-90.
33. Greco L, Romino R, Coto I et al. The first large population-based twin study of celiac disease. Gut 2002; 50: 624-28.
34. Greco L, Corazza G, Babron MC et al. Genome search in celiac disease. Am J Hum Genet 1998; 62: 669-75.
35. Nalui AT, Nilsson S, Gudjonsdottir AH et al. Genome-wide linkage analysis of Scandinavian affected sib-pairs supports presence of susceptibility loci for celiac disease on chromosomes 5 and 11. Eur J Hum Genet 2001; 9: 938-44.
36. Castigli E et al. TACI is mutant in common variable immunodeficiency and IgA deficiency. Nature Genet 2005; 37: 829-34.
37. Kasarda DD. Gluten and gliadin: precipitating factors in celiac disease. In: Maki M, Collin P, Visakopi JK eds. Proceedings of the 7th International symposium on celiac disease. 1996, 195-212.
38. Janatuinen EK, Pikkarainen PH, Kemppainen TA et al. A comparison of diets with and without oats in adults with celiac disease. N Eng J Med 1995; 333: 1033-37.
39. Storsrud S, Olsson M, Arvidsson LR et al. Adult celiac patients do tolerate large amounts of oats. Eur J Clin Nutrition. 2003; 57: 163-69.
40. Arentz-Hasen H, Fleckenstein B, Molberg O et al. The molecular basis for oat intolerance in patients with celiac disease. 2004; PLoS Med. 1(1) e1.
41. Sollid LM. Celiac disease: dissecting a complex inflammatory disorder. Nat Rev Immunol 2002; 2: 647-55.
42. Dietrich W, Ehnis T, Bauer M et al. Identification of tissue transglutaminase as the autoantigen in celiac disease. Nat Med 1997; 3: 797-801.
43. Anderson RP, Degano P, Godkin AJ, Jewell DP, Hill AV. In vivo antigen challenge in celiac disease identifies a single transglutaminase-modified peptide as the dominant A-gliadin T-cell epitope. Nat Med 200; 191: 603-12.
44. Shan L, Molberg O, Parrot I et al. Structural basis for gluten-intolerance in celiac sprue. Science 2002; 297: 2275-79.
45. Price HL, Gazzard BG, Dawson AM. Steatorrhoea in the elderly. BMJ 1997; 1: 1582-84.
46. Montgomery RD, Haroubi NY, Mike NH, Chesner IM, Asquith P. Causes of malabsorption in the elderly. Age Ageing 1986; 15: 235-40.
47. Jabri B, de Serre NP, Cellier C et al. Selective expansion of intraepithelial lymphocytes expressing the HLA-E-specific natural killer receptor CD94 in celiac disease. Gastroenterology 2000; 118: 867-79.
48. Sollid LM and Jabri B. Is celiac disease an autoimmune disorder? Curr Opin Immunol 2005; 17: 595-600.
49. Hadjivassiliou M, Gibson A, Davies-Jones GAB et al. Does crypt gluten sensitivity play a part in neurological illness? Lancet 1996; 347: 369-71.
50. Hadjivassiliou M, Grunewald RA, Chattopadhyay AK et al. Clinical, radiological, neurophysiological and neuropathological characteristics of gluten ataxia. Lancet 1998; 352: 1582-85.
51. Ventura et al. Duration of exposure to gluten and risk for autoimmune disorders in patients with celiac disease. SIGEP Study Group for Autoimmune Disorders in Celiac Disease. Gastroenterology 1999; 117: 297-303.
52. Vijamaa M et al. Celiac disease, autoimmune disease and gluten exposure. Scand J Gastroenterol 2005; 40: 437-43.
53. Cooke WT, Holmes GKT. Coeliac disease. Edinburgh: Churchill Livingston, 1984.
54. Midhagen G, Jarnerot G, Kraaz W. Adult celiac disease within a defined geographic area in Sweden: a study of prevalence and associated disease. Scand J Gastroenterol 1988; 23: 1000-04.
55. Howdle PD, Losowsky MS. Celiac disease in adults. In: Marsh MN ed. Celiac disease. Oxford: Blackwell, 1992: 49-80.
56. Kirby J, Fielding JF. Very adult coeliac disease. The need for jejunal biopsy in the middle-aged and elderly. Ir Med J 1984; 77: 35-36.
57. Walters JRF. Bone-mineral density in coeliac disease. Gut 1994; 35: 150-51.
58. Carceni MP, Molteni N, Bardella MT et al. Bone and mineral metabolism in adult celiac disease. Am J Gastroenterol 1988; 83: 274-77.
59. Ferguson MN. Celiac disease with recurrent apthae. Gut 1980; 21: 223-26.
60. Cook WT, Smith WT. Neurological disorders associated with adult celiac disease. Brain 1966; 89: 683-722.
61. Kaplan JG, Pack D, Horoupian D et al. Distal axonopathy with chronic gluten enteropathy: a treatable disorder. Neurology 1988; 38: 642-45.
62. Hardoff D, Sharf B, Berger A. Myopathy as a presentation of celiac disease. Dev Med Child Neurol 1980; 22: 781-83.
63. Collin P, Pirtilla T, Nurmikko T et al. Celiac disease, brain atrophy and dementia. Neurology 1991; 41: 372-75.
64. Hu WT, Murray JA, Greenaway MC et al. Cognitive imapairment and celiac Dis Arch Neurol 2006; 63: 1440-46.
65. West J, Logan RF, Hubbard RB, Card TR. Risk of schizophrenia in people with coeliac disease, ulcerative colitis and Crohn's disease: a general population-based study. Aliment Pharmacol Ther 2006 23; 71-74.
66. Gobbi G, Bouquet F, Greco L et al. Celiac disease, epilepsy and cerebral calcifications. Lancet 1992; 340: 439-43.
67. Christenson OB, Hindsen M, Svensson A. Natural history of dermatitis herpetiformis in southern Sweden. Dermatologica 1986; 73: 271-77.
68. Hakenen M, Luotola K, Salmi J, Laippala P, Kaikinen K, Collin P. Autoimmune thyroid disease in adult celiac disease. Digest Dis Sci 2000; 46: 2631-35.
69. Collin P, Reunala T, Pukkala E et al. Celiac disease - associated disorders and survival. Gut 1994; 35: 1215-18.
70. Holmes GK, Prior P, Lane MR et al. Malignancy in coeliac disease - effect of gluten-free diet. Gut 1989; 30: 333-38.
71. Rampertab SD, Forde KA, Green PH. Small-bowel neoplasia in celiac disease. Gut 2003; 52: 1211-14.
72. Green PH, Fleischauer AT, Bhagat G et al. Risk of malignancy in patients with celiac disease. Am J Med 2003; 115: 191-95.
73. Smedby KE, Akerman M, Hildebrand H et al. Malignant lymphomas in celiac disease: evidence of increased risks for lymphoma types other than enteropathy-type T-cell lymphoma. Gut 2005; 54: 54-59.
74. Catassi C, Fabriani E, Corrao G et al. Risk of non-Hodgkin lymphoma in celiac disease. JAMA 2002; 287: 1413-19.
75. Card TR, West J, Holmes GK. Risk of malignancy in diagnosed coeliac disease: a 24-year prospective, population-based, cohort study. Aliment Pharmacol Ther 2004; 20: 769-75.
76. Farre C, Domingo-Domenench E, Font R et al. Celiac disease and lymphoma risk: a multi-centre case-control study in Spain. Dig Dis Sci 2004; 49: 408-12.
77. Cellier C, Patey N, Mauvieux L et al. Abnormal intestinal intraepithelial lymphocytes in refractory sprue. Gastroenterology 1998; 114: 471-81.
78. Cellier C, Delabesse E, Helmer C et al. Refractory sprue, celiac disease, and enteropathy-associated T-cell lymphoma. French Celiac Disease Study Group. Lancet 2000; 356: 203-08.
79. Hallert C, Tobiasson P, Walen A. Serum folate determinations in tracing adult coeliac. Scand J Gastroenterol 1981; 16: 263-67.
80. Fine KD. The prevalence of occult gastrointestinal bleeding in celiac sprue. N Engl J Med 1996; 334: 1163-67.
81. Dewar D, Ciclitera PJ. Clinical features and diagnosis of celiac disease. Gastroenterology 2005; 128: S19-24.
82. Bardella MT, Minoli G, Radaelli F, Quatrini M, Bianchi PA, Conte D. Re-evaluation of duodenal endoscopic markers in the diagnosis of celiac disease. Gastrointest Endosc 2000; 51: 714-16.
83. Sjoberg K, Alm R, Ivarsson A et al. Prevalence and clinical significance of gliadin antibodies in healthy children and adults. Scand J Gastroenterol 1994; 29: 248-54.
84. Grodizinsky E, Franzen L, Hed J, Strom M. High prevalence of celiac disease in healthy adults revealed by antigliadin antibodies. Ann Allergy 1992; 69: 66-70.
85. James MW, Scott BB. Endomysial antibody in the diagnosis and management of celiac disease. Postgrad Med J 2000; 76: 466-68.
86. Horvath K, Hill ID. Anti-tissue transglutaminase antibody as first-line screening for celiac disease; goodbye antigliadin tests? Am J Gastroenterol 2002; 97: 2702-04.
87. McMillan SA, Haughton DA, Biggart JD et al. Predictive value for celiac disease of antibodies to gliadin, endomysium, and jejunum in patients attending for jejunal biopsy. BMJ 1991; 303: 1163-65.
88. Attia L, Holt PR. Serological testing for celiac disease in the elderly. Gastroenterology 1995; 111: 2053.
89. Hill ID. What are the sensitivity and specificity of serological tests for celiac disease? Do sensitivity and specificity vary in different populations? Gastroenterology 2005; 128(4 suppl 1): S25-32.
90. Hopper AD et al. Pre-endoscopy serological testing for coeliac disease: evaluation of a clinical decision tool. BMJ 2007; 334: 729.
91. Stenson WF, Newbery R, Lorenz R, Baldus C. Increased prevalence of celiac disease and need for screening among patients with osteoporsis. Arch Intern Med 2005; 165: 393-99.
92. Scott EM, Gaywood I, Scott BB. Guidelines for osteoporosis coeliac disease and inflammatory bowel disease. British Society of Gastroenterology. Gut 2001; 46(suppl 1): 1-8.
93. Ryan BM, Kelleher D. Refractory celiac disease. Gastroenterology 2000; 119: 243-51.
94. Swinson CM, Coles EC, Slavin G, Booth CC. Coeliac disease and malignancy. Lancet 1983; 1: 111-15.
95. Hourihane DO'B, Weir DG. Malignant celiac syndrome. Report of two cases with malabsorption and microscopic foci of intestinal lymphoma. Gastoenterology 1970; 59: 130-39.
96. Fry L. Dermatitis herpetiformis. In: Marsh MN ed. Coeliac disease. Oxford: Blackwell Scientific Publications, 1992: 81-104.
97. Baer AN, Bayless TM, Yardley JH. Intestinal ulceration and malapsorption syndromes. Gastroenterology 1980; 79: 754-65.
98. Matuchansky C, Colin R, Hemet J et al. Cavitation of mesenteric lymph nodes, splenic atrophy and a flat small intestine mucosa: report of 6 cases. Gastroenterology 1984; 87: 606-14.
99. Al-Toma A, Goerres M, Meijer JW, Von Bloomberg et al. Cladribine therapy in refractory celiac disease with aberrant T cells. Clin Gastroenterol Hepatol 2006; 4: 1322-327.
100. Al-Toma A, Visser OJ, VanRoessel HM et al. Autologous haematopoietic stem cell transplantation in refractory celiac disease with aberrant T cells. Blood 2007; 109: 2243-49.
101. Srinivasan U, Leonard N, Jones E et al. Absence of oats toxicity in adult coeliac disease. BMJ 1996; 313: 1300-01.
102. Weinstein WM, Saunders DR, Tytag GN, Rubin CE. Collagenous sprue - an unrecognized type of malabsorption. N Engl J Med 1970; 283: 1297-301.
103. Love AHG, Elmes M, Golden MK et al. Zinc deficiency and celiac disease. In: McNicholl B, McCarthy CF, Fottrel PF eds. Perspectives in coeliac disease. Lancaster, UK: International Medical Publishers, 1977: 335-42.
104. Hamilton JD, Chambers RA, Wynn-Williams A. Role of gluten, prednisolone and azathioprine in non-responsive coeliac disease. Lancet 1976: 1: 1213-16.
105. Bernstein EF, Whitington PF. Successful treatment of atypical sprue in an infant with cyclosporine. Gastroenterology 1988; 95: 199-204.
106. Molberg O, Uhlen AK, Jensen T et al. Mapping of gluten T-cell epitopes in bread wheat ancestors: implications for celiac disease. Gastroenterology 2005; 128: 393-401.
107. Shan L, Molberg O, Parrot I et al. Structural basis for gluten intolerence in celiac sprue. Science 2002; 297: 2275-79.
108. Fasano A, Not T, Wang W et al. Zonulin, a newly discovered modulator of intestinal permeability, and its expression in celiac disease. Lancet 2000; 355: 1518-19.
109. Kim CY, Quarsten H, Bergseng E et al. Structural basis for HLA-DQ2-mediated presentation of gluten epitopes in celiac disease. Proc Natl Acad. Sci USA 2004; 101: 4175-79.